⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REPL News
Replimune Group, Inc.
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma
globenewswire.com
REPL
Investor Alert: Deadline Approaching to Join Replimune Group, Inc. (REPL) Class Action - Contact Levi & Korsinsky
accessnewswire.com
REPL
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REPL
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 - Replimune Group, Inc. (REPL)
accessnewswire.com
REPL
SueWallSt Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - REPL
prnewswire.com
REPL
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL
prnewswire.com
REPL
Investor Alert: Deadline Approaching to Join Replimune Group, Inc. (REPL) Class Action - Contact Levi & Korsinsky
accessnewswire.com
REPL
Pomerantz LLP Posts Reminder: Legal Action Filed Against Replimune Group, Inc. – REPL
accessnewswire.com
REPL
Levi & Korsinsky Notifies Replimune Group, Inc. (REPL) Investors - Lead Plaintiff Deadline on October 5, 2026
accessnewswire.com
REPL
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
REPL